February 01, 2005
AMA says Doctors May Over-Prescribe Drugs
The Australian Medical Association (AMA) has admitted there is a possibility that some doctors are over-prescribing ADHD medication to Western Australian children.
Figures from the Health Insurance Commission have revealed the drug dexamphetamine was prescribed to patients aged under 20 at four times the rate of other states last year.
Continue reading "AMA says Doctors May Over-Prescribe Drugs"December 22, 2004
Ritalin has Similar Effect for Children with Reading Disorders
The drug methylphenidate (brand name Ritalin) increased activity in brains of children with attention-deficit/hyperactivity disorder (ADHD) as well as those with a reading disorder, researchers at Yale report in the American Journal of Psychiatry.
"During a test of divided attention, Ritalin increased activation in the basal ganglia, a structure of the brain involved in cognition and behavior," said first author Keith Shafritz, former graduate student in the interdepartmental Neuroscience Program at Yale and now a research associate at Duke University Medical Center. "We saw this activation in children with ADHD and those with reading disorder."
FDA Warning on Strattera for ADHD
The Food and Drug Administration (FDA) is advising health care professionals about a new warning for Strattera, a drug approved for attention deficit hyperactivity disorder (ADHD) in adults and children. The labeling is being updated with a bolded warning about the potential for severe liver injury following two reports (a teenager and an adult) in patients who had been treated with Strattera for several months, both of whom recovered.
The labeling warns that severe liver injury may progress to liver failure resulting in death or the need for a liver transplant in a small percentage of patients. The labeling also notes that the number of actual cases of severe liver injury is unknown because of under-reporting of post-marketing adverse events.
